
Feature|Articles|June 23, 2026
Pharmacists Are at the Forefront of Technology in Diabetes Care
Author(s)Ashley Gallagher, MA
Diabetes technology shifts to continuous glucose monitoring, automated insulin delivery, and connected pens, empowering pharmacists to guide safer care.
Advertisement
Advertisement
The landscape of diabetes management is undergoing a profound transformation, moving away from isolated fingerstick readings toward a world of continuous data and automated therapy. Although diabetes technology has historically been divided into insulin administration and glucose measurement, the field now encompasses a complex ecosystem of hardware and software, including continuous glucose monitors (CGMs), automated insulin delivery (AID) systems, and connected insulin pens.1
Related to this article

Our hosts explore why ketone monitoring matters, what pharmacists should know about Libre Duo, and how patient education can support proactive care management.

Despite Gazyva being the first drug accepted to treat this type of nephropathy, it’s already approved for a host of other conditions.

The Milken Institute released survey results alongside new data regarding the need for pharmacists in extending effective GLP-1 care.

Findings from a meta-analysis of over 125 clinical trials led the agency to require a class-wide label change.

An abstract from the American Heart Association's Scientific Sessions 2026 reveals the continuous expansion of the GLP-1 medication class.

Owners believe clean plan-to-patient matching before January 1 is one of the simplest ways to protect cash flow in 2027.

The PAHO confirmed the loss after more than 12 months of continuous transmission, putting renewed focus on pharmacists' role in closing vaccination gaps.
Advertisement
Advertisement

